The Patent Finder
US

Methods and Pharmaceutical Compositions for Reliable Achievement of Acceptable Serum Testosterone Levels

US 7,718,640 In force
OverviewFamilyAssignmentsSources & methods

Term ends Mar 14, 2027 · High confidence

Filed Mar 12, 2004 as application 10/798,780 · Granted May 18, 2010
Base term plus 1097 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2004 2027
Clock starts
Mar 12, 2004
Term ends
Mar 14, 2027
Granted
May 18, 2010
base term patent term adjustment fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,097
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 1097 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Mar 12, 2004, when this application, 10/798,780, was filedMar 12, 2024High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+1097 days, USPTO patent term adjustment recordMar 14, 2027High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderMar 14, 2027High confidence

This family

US 7,718,640this patent
Mar 2027
Mar 2027
US 8,338,395In force
May 2027
May 2027
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Oct 22, 2004
Reel 15914, frame 882
Hubler, Doris; Fricke, Sabine; Ingwersen, Jan-peter; Kuhnz, WilhelmSchering AktiengesellschaftAssignment of Assignor's Interest
Oct 30, 2009
Reel 23450, frame 959
Bayerschering Pharma AG, Formerly Known as Schering AktiengesellschaftEndo Pharmaceuticals Solutions Inc., Formerly Known as Indevus Pharmaceuticals, Inc.License
Feb 13, 2010
Reel 23928, frame 628
Endo Pharmaceuticals Inc.JPMorgan Chase Bank, N.A., as Administrative AgentConfirmatory Grant of Security Interest in United States Patents (Exclusively Licensed Patents)
Dec 9, 2010
Reel 25456, frame 172
Endo Pharmaceuticals Inc.JPMorgan Chase Bank, N.A., as Administrative AgentConfirmatory Grant of Security Interest in United States Patents (Exclusively Licensed Patents)
Dec 9, 2010
Reel 25456, frame 778
JPMorgan Chase Bank, N.A., as Administrative AgentEndo Pharmaceuticals Inc.Release of Security Interest Recorded at Reel/Frame 23928/628
Jul 8, 2011
Reel 26561, frame 978
Endo Pharmaceuticals Inc.Morgan Stanley Senior Funding, Inc., as Administrative AgentSecurity Interest in Exclusively Licensed Patents
Jul 12, 2011
Reel 26577, frame 357
JPMorgan Chase Bank N.A., as Administrative AgentEndo Pharmaceuticals Inc.Release of Security Interest in Exclusively Licensed Patents Recorded at Reel/Frame 25456/172
Nov 28, 2012
Reel 29373, frame 170
Bayer Schering Pharma AktiengesellschaftBayer Pharma AktiengesellschaftChange of Name
Jun 12, 2013
Reel 30596, frame 123
Bayer Pharma AktiengesellschaftBayer Intellectual Property GmbHChange of Name
Mar 3, 2014
Reel 32380, frame 157
Morgan Stanley Senior Funding, Inc., as Administrative AgentEndo Pharmaceuticals Solutions Inc.Release of Patent Security Interest in Exclusively Licensed Patents
Mar 20, 2014
Reel 32491, frame 620
Endo Pharmaceuticals, Inc.Deutsche Bank AG New York Branch, as Collateral AgentGrant of Security Interest in Licensed Patents
Mar 24, 2014
Reel 32513, frame 255
Morgan Stanley Senior Funding, Inc., as Administrative AgentEndo Pharmaceuticals Inc.Corrective Assignment to Correct the Name of Receiving Party in Release of Patent Security Interest in Exclusively Licensed Patents Previously Recorded on Reel 032380 Frame 0157. Assignor(S) Hereby Confirms the Release of Security Interest in Exclusively Licensed Patents..
Apr 29, 2014
Reel 32796, frame 29
Bayer Schering Pharma AktiengesellschaftBayer Pharma AktiengesellschaftPreviously Recorded Assignment (on 11/28/2012-029373/0170) Contained the English Language Translation of the Commercial Register. the German Version of the Commercial Register, English Translation and Translator Certificate Now Submitted.
Apr 28, 2017
Reel 42362, frame 1
Deutsche Bank AG New York BranchEndo Pharmaceuticals, Inc.; Endo Pharmaceuticals Solutions, Inc.; Astora Women's Health Holdings, LLCRelease of Security Interest
Apr 28, 2017
reel/frame not recorded
Deutsche Bank AG New York BranchEndo Pharmaceuticals, Inc.Release of Security Interest
Apr 28, 2017
reel/frame not recorded
Deutsche Bank AG New York BranchEndo Pharmaceuticals Solutions, Inc.Release of Security Interest
Apr 28, 2017
reel/frame not recorded
Deutsche Bank AG New York BranchAstora Women's Health Holdings, LLCRelease of Security Interest
Jan 23, 2023
Reel 62448, frame 602
Bayer Intellectual Property GmbHGrünenthal GmbHAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited